Zobrazeno 1 - 10
of 79
pro vyhledávání: '"L. Muñoz-Espinosa"'
Autor:
Abigail Hernandez-Barragan, Z. Medina-Avila, D. Montes-de-Oca-Angeles, M. Lemus-Peña, M. Hernandez-Santillan, M. Martínez-Castillo, J.L. Pérez-Hernández, F. Higuera-De la Tijera, D. Santana-Vargas, E. Montalvo-Jave, P. Cordero-Pérez, L. Muñoz-Espinosa, J. Córdova-Gallardo, A. Torre-Delgadillo, D. Kershenobich, G. Gutiérrez-Reyes
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 100948- (2023)
Introduction and Objectives: IL-1β is a proinflammatory key cytokine that participates in the progression of liver disease. Its antagonist IL-1RA mediates damage limitation; its increase is associated with positive effects on chronic liver diseases.
Externí odkaz:
https://doaj.org/article/cd206fa58bce47aa8bf4cd1fa8b7fc2c
Autor:
Daniel Montes de Oca-Angeles, M. Lemus-Peña, A. Hernandez-Barragan, M. Hernández-Santillán, Moisés Martinez-Castillo, Z. Medina-Avila, D. Santana-Vargas, A. Torre-Delgadillo, J.L. Pérez-Hernández, F. Higuera-De la Tijera, P. Cordero-Pérez, L. Muñoz-Espinosa, D. Kershenobich, G. Gutiérrez-Reyes
Publikováno v:
Annals of Hepatology, Vol 28, Iss , Pp 100975- (2023)
Introduction and Objectives: We recently published that in the serum of patients with chronic Hepatitis C, there are high concentrations of inactive Matrix Metalloproteinases (MMP). However, the MMP has not been studied in other liver diseases. This
Externí odkaz:
https://doaj.org/article/bbb0372721024ba1807e9b4640f7d637
Autor:
R. Contreras-Omaña, J.A. Velarde-Ruiz Velasco, G.E. Castro-Narro, O. Trujillo-Benavides, F. Zamarripa-Dorsey, A.A. Reyes-Dorantes, L. Muñoz-Espinosa, I. Aiza-Haddad, M. Castillo-Barradas, E. Cerda-Reyes, L.E. Cisneros-Garza, J. Flores-Calderón, E.S. García-Jiménez, M.F. Higuera-de-la-Tijera, M.A. Lira-Pedrín, E. Marquez-Guillén, C. Moctezuma-Velázquez, R. Moreno-Alcántar, S.G. Noyola-Cedillo, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J.M. Remes-Troche, M.T. Rizo-Robles, H. Rodríguez-Hernández
Publikováno v:
Revista de Gastroenterología de México, Vol 87, Iss 1, Pp 80-88 (2022)
Resumen: El término colestasis se refiere a la retención de ácidos biliares ya sea dentro del hepatocito o en los ductos biliares de cualquier calibre. Por laboratorio, se define por la elevación de fosfatasa alcalina arriba de 1.67 veces su valo
Externí odkaz:
https://doaj.org/article/d94ce840665442f98183b6675b66de54
Autor:
R. Contreras-Omaña, J.A. Velarde-Ruiz Velasco, G.E. Castro-Narro, O. Trujillo- Benavides, F. Zamarripa-Dorsey, A.A. Reyes-Dorantes, L. Muñoz-Espinosa, I. Aiza-Haddad, M. Castillo-Barradas, E. Cerda-Reyes, L.E. Cisneros-Garza, J. Flores-Calderón, E.S. García-Jiménez, M.F. Higuera-de-la-Tijera, M.A. Lira-Pedrín, E. Marquez-Guillén, C. Moctezuma-Velázquez, R. Moreno-Alcántar, S.G. Noyola-Cedillo, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J.M. Remes-Troche, M.T. Rizo-Robles, H. Rodríguez-Hernández
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 87, Iss 1, Pp 80-88 (2022)
The term cholestasis refers to bile acid retention, whether within the hepatocyte or in the bile ducts of any caliber. Biochemically, it is defined by a level of alkaline phosphatase that is 1.67-times higher than the upper limit of normal. Cholestat
Externí odkaz:
https://doaj.org/article/92e5c6bc95e343fdbc379d2bbd56f4eb
Autor:
A Hernandez-Barragan, D Montes-de-Oca-Angeles, M Lemus-Peña, M Hernandez-Santillan, KZ Medina-Avila, M Martínez-Castillo, JL Pérez-Hernández, F Higuera-De la Tijera, D Santana-Vargas, P Cordero-Pérez, L Muñoz-Espinosa, A Torre-Delgadillo, J Córdova-Gallardo, D Kershenobich, G Gutiérrez-Reyes
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100864- (2022)
Introduction and Objectives: This study aimed to evaluate serum concentration of IL-1β and IL-1RA in subjects with alcoholic liver disease (ALD), chronic hepatitis C (CHC) and non-alcoholic fatty liver disease (NAFLD). Materials and methods: A cross
Externí odkaz:
https://doaj.org/article/6224b37b3a49446fa48424f6d8eee303
Autor:
M Lemus-Peña, D Montes de Oca-Ángeles, M Hernandez-Santillan, A Hernandez-Barragan, D Santana-Vargas, M Martinez-Castillo, Z Medina-Avila, A Torre-Delgadillo, JL Pérez-Hernández, F Higuera-De la Tijera, P Cordero-Pérez, L Muñoz-Espinosa, D Kershenobich, G Gutiérrez-Reyes
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100868- (2022)
Introduction and Objective: This study aimed to evaluate serum concentration of MMP-2 and -9 in different etiologies of liver disease also according to fibrosis stages. Materials and methods: Cross-sectional multicentric study, including subjects wit
Externí odkaz:
https://doaj.org/article/6342f71497f44adaa40351544762ae92
Autor:
D Montes de Oca-Angeles, M Lemus-Peña, A Hernandez-Barragan, M Hernández-Santillán, M Martinez-Castillo, D Santana-Vargas, Z Medina-Avila, A Torre-Delgadillo, JL Pérez-Hernández, F Higuera-De la Tijera, P Cordero-Pérez, L Muñoz-Espinosa, D Kershenobich, G Gutiérrez-Reyes
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100869- (2022)
Introduction and Objectives: This study aimed to evaluate serum concentrations of MMP-7 in different liver etiologies and according to fibrosis stage. Materials and methods: A cross-sectional and multicenter study was carried out, including subjects
Externí odkaz:
https://doaj.org/article/3748ac3293af4c1a9fee1fe241754208
Autor:
K López-Riojas, KA Galán-Huerta, AF Ruiz-Higareda, L Muñoz-Espinosa, P Cordero-Pérez, D Arellanos-Soto, S Lozano-Sepulveda, AM Rivas-Estilla
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100848- (2022)
Introduction and Objective: Death due to liver damage caused by the hepatitis C virus (HCV) represents one of the most frequent health threats in Mexico. However, the complete genome of HCV has not yet been sequenced. The aim of this study was to obt
Externí odkaz:
https://doaj.org/article/0bcaa6c80c7f4158bd00d1a717f752f7
Autor:
K López-Riojas, KA Galán-Huerta, AF Ruiz-Higareda, L Muñoz-Espinosa, P Cordero-Pérez, D Arellanos-Soto, S Lozano-Sepúlveda, AM Rivas-Estilla
Publikováno v:
Annals of Hepatology, Vol 27, Iss , Pp 100849- (2022)
Introduction and Objectives: Death due to liver damage caused by hepatitis C virus (HCV), this agent represents one of the most frequent health threats in Mexico. Now direct-acting antiviral agents (DAA's) are available to treat HCV infections. Never
Externí odkaz:
https://doaj.org/article/e35c825258bd49909d62b3b549d3d9c4
Autor:
A. Villarreal-Benítez, P. Cordero-Pérez, N.F. Cruz-Urista, E. Cienfuegos-Pecina, D. Villarreal-Garza, D.P. Moreno-Peña, L. Muñoz-Espinosa, L.C. Treviño-Lozano, L. Torres-González
Publikováno v:
Annals of Hepatology, Vol 19, Iss , Pp 10- (2020)
Externí odkaz:
https://doaj.org/article/6afa35a190ae4a8c8d7457285b12c938